Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Reviva Pharmaceuticals Hldg Inc (RVPH)

Reviva Pharmaceuticals Hldg Inc (RVPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Reviva Pharmaceuticals Hldg Inc 10080 N. WOLFE ROAD SUITE SW3-200 CUPERTINO CA 95014 USA

www.revivapharma.com Employees: 14 P: 408-501-8881 F: 408-904-6270

Sector:

Medical

INDUSTRY GROUPING:

Medical - Drugs

Description:

Reviva Pharmaceuticals Inc. is a clinical stage pharmaceutical company. It engages in developing therapies to address unmet medical needs in the areas of central nervous system, cardiovascular, metabolic and inflammatory diseases. The company's lead product candidate includes RP5063, for the treatment of schizophrenia, bipolar disorder and major depressive disorder. Reviva Pharmaceuticals Inc., formerly known as Tenzing Acquisition Corp., is based in NEW YORK.

Key Statistics

Overview:

Market Capitalization, $K 29,984
Enterprise Value, $K 16,504
Shares Outstanding, K 115,059
Float, K 104,819
% Float 91.10%
Short Interest, K 23,574
Short Float 20.49%
Days to Cover 4.85
Short Volume Ratio 0.56
% of Insider Shareholders 8.90%
% of Institutional Shareholders 63.18%

Financials:

Annual Sales, $ 0 K
Annual Net Income, $ -29,920 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -4,010 K
EBIT, $ -22,920 K
EBITDA, $ -22,920 K

Growth:

1-Year Return -85.52%
3-Year Return -94.51%
5-Year Return -96.99%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth -328.57%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.06 on 11/13/25
Next Earnings Date 03/30/26
Earnings Per Share ttm -0.46
EPS Growth vs. Prev Qtr 50.00%
EPS Growth vs. Prev Year 76.00%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

RVPH Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % -187.50%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 5.43
Book Value/Share 0.05
Interest Coverage -1,494.00
60-Month Beta 0.06
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar